The panelists all introduce themselves - they now work in research integrity at a publisher, but started in very different careers. It is a relatively new type of career, and often started with a volunteer role in ethics. #SSP2023
Each panelist will talk about their current job and how they deal with certain cases.
YF: The right thing to do is not always the easiest or most pleasant thing to do. Our journal suspected misconduct and rejected a manuscript, and we reported it to the institution. #SSP2023
YF: Another case: A peer reviewer reported that a manuscript was submitted to two different publishers ( how to deal with that while respecting editorial confidentiality? #SSP2023
LL: @IEEEorg has retracted 1000s of conference abstracts, our org is currently responsible for 25% of all retractions. We received complaints about quality of certain conference abstracts and decided to investigate thoroughly (100,000 papers)
See: science.org/doi/10.1126/sc… #SSP2023
LL: we did not just retract these papers, we closed certain chapters and let certain volunteers go.
We now have much stricter quality requirements for new IEEE conferences and higher level of technical review.
But regaining trust will be a slow process. #SSP2023
YF: Publishers can review, but not legally investigate, we cannot e.g. confiscate lab books. That is up to the research institutions. We also do not deal with the people behind allegations, but we deal with the scholarly record, the papers.
Q from the audience: how careful are you about sharing specifics on how e.g. paper mill activity was exposed? Sharing such details might alert fraudsters how to fraud better.
MS: we share that we found a paper mill, but we do not share all intelligence we have gained. #SSP2023
LL: It is frustrating that we retract papers, but cannot go after the people who make money off these paper mills. There is even Twitter account tweeting about social media advertisements: @fake_journals - but who uncovers these organizations? #SSP2023
Audience Q: Based on what you learned, how did your organization learn from that and now do differently?
YF: We focus more on e.g. tools to investigate image integrity.
MS: We introduced new screening tools and guidelines.
LL: AI tools will be both threat as opportunity. #SSP2023
Q: Does this increased screening include your preprint articles?
LL: Yes, we are looking into policies for that. #SSP2023
Q: What is the future of research integrity and what are you most excited about?
YF: There will be more bad stuff in the future. But I am excited that we will have increased tools of dealing with that. #SSP2023
LL: There will be more paper mills in the future, but at least that will keep me employed!
MS: Standardization of workflow of the editorial process will increase screening. And I am excited about collaboration.
HS: Thank you all for your participation. #SSP2023
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The retraction notice states that 'The Regenerative Research Foundation conducted an investigation following its policies and the NIH Office of Research Integrity guidelines and determined that there had been image manipulation in these figures'.
After the coffee, I will attend one of the parallel sessions: Charleston Trendspotting: Forecasting the Future of Trust and Transparency.
With Leah Hinds @chsconf and @lisalibrarian and a "Future's Wheel" #SSP2023
(I am a bit nervous about what a Futures Wheel is and the pieces of paper and markers on some of the tables - if this is too interactive or too buzzwordy, I might run to the nearest #introvert corner). #SSP2023
Futures Wheel: there is an event/trend in the middle, some direct effects around it, secondary effects a bit further out, etc. Effects can be positive/negative. The further out, the harder it is to predict them. Effects can occur multiple times. #SSP2023 mindtools.com/a3w9aym/the-fu…
Good morning from Portland, OR, from the #SSP2023@ScholarlyPub, where I will attend the plenary session "The Evolving Knowledge Ecosystem" about the economic pressures and the greatest challenges shaping the scholarly publishing industry.
Roger Schonfeld @rschon will be moderating this panel, and opens the discussion with asking what the purpose of scholarly publishing is or should be. @amy_brand : we not only deliver research contents but we are really integral to the academic ecosystem.
French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for "the largest 'unauthorised' clinical trial ever seen" into the use of hydroxychloroquine to treat Covid-19 france24.com/en/europe/2023…
The tweet at the start of this thread has resulted in a lot of discussion and critique, so if you have something valid to say, I encourage you to comment on the preprint on @PubPeer: pubpeer.com/publications/4…
One of these papers is from the Guangzhou University of Chinese Medicine and @UnivOfKansas.
Together with earlier retractions from this group of authors, it raises severe concerns about this @NIEHS and Natural Science Foundation of Guangdong Province-sponsored research.
As pointed out by @bsPyt7dmnBKaebN, this 2020 paper shares several figures with a 2014 and a 2020 paper from two different group of researchers.
Here are Figures 1, 2, 3, and 4 from the three papers compared. Blots and plots look identical. pubpeer.com/publications/D…
Several other figures appear to have been copied from two other papers, again from different researchers.
There appears to be almost no original data in this paper.
Stanford president dodges research misconduct questions
Amid Tessier-Lavigne’s defense, unanswered questions and contradictory statements @tab_delete writes @StanfordDaily
'He has canceled public appearances, demanded retraction of The Daily’s reporting through his lawyers, deactivated the website for his public office hours and declined to respond to dozens of inquiries.'
'When he has commented on the allegations surrounding his work, Tessier-Lavigne has routinely provided accounts that contradict publicly available information.'
Great investigation by Polk-award-winner @tab_delete